• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不断变化的阿片类药物危机:发展、挑战与机遇。

The changing opioid crisis: development, challenges and opportunities.

机构信息

National Institute on Drug Abuse, Bethesda, MD, 20892, USA.

出版信息

Mol Psychiatry. 2021 Jan;26(1):218-233. doi: 10.1038/s41380-020-0661-4. Epub 2020 Feb 4.

DOI:10.1038/s41380-020-0661-4
PMID:32020048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7398847/
Abstract

The current opioid epidemic is one of the most severe public health crisis in US history. Responding to it has been difficult due to its rapidly changing nature and the severity of its associated outcomes. This review examines the origin and evolution of the crisis, the pharmacological properties of opioids, the neurobiology of opioid use and opioid use disorder (OUD), medications for opioid use disorder (MOUD), and existing and promising approaches to prevention. The results of the review indicate that the opioid epidemic is a complex, evolving phenomenon that involves neurobiological vulnerabilities and social determinants of health. Successfully addressing the epidemic will require advances in basic science, development of more acceptable and effective treatments, and implementation of public health approaches, including prevention. The advances achieved in addressing the current crisis should also serve to advance the science and treatment of other substance use disorders.

摘要

目前的阿片类药物泛滥危机是美国历史上最严重的公共卫生危机之一。由于其快速变化的性质和相关后果的严重性,应对这一危机一直具有挑战性。本综述考察了危机的起源和演变、阿片类药物的药理学特性、阿片类药物使用和阿片类药物使用障碍(OUD)的神经生物学、阿片类药物使用障碍的药物治疗(MOUD)以及现有的和有前途的预防方法。综述结果表明,阿片类药物泛滥危机是一种复杂的、不断演变的现象,涉及神经生物学脆弱性和健康的社会决定因素。成功应对这一危机需要基础科学的进步,开发更可接受和有效的治疗方法,并实施公共卫生方法,包括预防。在应对当前危机方面取得的进展也应该有助于推进其他物质使用障碍的科学和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6de/7398847/ed14182a28d9/nihms-1551700-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6de/7398847/ed14182a28d9/nihms-1551700-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6de/7398847/ed14182a28d9/nihms-1551700-f0001.jpg

相似文献

1
The changing opioid crisis: development, challenges and opportunities.不断变化的阿片类药物危机:发展、挑战与机遇。
Mol Psychiatry. 2021 Jan;26(1):218-233. doi: 10.1038/s41380-020-0661-4. Epub 2020 Feb 4.
2
Deploying science to change hearts and minds: Responding to the opioid crisis.运用科学改变观念:应对阿片类药物危机。
Prev Med. 2019 Nov;128:105780. doi: 10.1016/j.ypmed.2019.105780. Epub 2019 Jul 15.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Responding to the US opioid crisis: leveraging analytics to support decision making.应对美国阿片类药物危机:利用分析技术支持决策。
Health Care Manag Sci. 2023 Dec;26(4):599-603. doi: 10.1007/s10729-023-09657-0. Epub 2023 Oct 7.
5
American College of Preventive Medicine: Addressing the Opioid Epidemic Through a Prevention Framework.美国预防医学学院:通过预防框架应对阿片类药物泛滥
Am J Prev Med. 2022 Sep;63(3):454-465. doi: 10.1016/j.amepre.2022.04.021. Epub 2022 Jun 22.
6
Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.阿片类药物戒断症状是慢性阿片类药物使用和阿片类药物使用障碍的后果:目前的认识和管理方法。
J Clin Pharm Ther. 2020 Oct;45(5):892-903. doi: 10.1111/jcpt.13114. Epub 2020 Jan 27.
7
News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic.新闻媒体在阿片类药物流行期间对阿片类药物使用障碍的药物治疗进行报道。
Health Aff (Millwood). 2019 Apr;38(4):643-651. doi: 10.1377/hlthaff.2018.05075.
8
Responding to the Opioid Epidemic: Educational Competencies for Pain and Substance Use Disorder from the Medical Schools of the University of California.应对阿片类药物流行:加利福尼亚大学医学院的疼痛和物质使用障碍教育能力。
Pain Med. 2021 Feb 4;22(1):60-66. doi: 10.1093/pm/pnaa399.
9
The Opioid Epidemic and the State of Stigma: A Pennsylvania Statewide Survey.阿片类药物流行与污名化状况:宾夕法尼亚州全州范围调查
Subst Use Misuse. 2022;57(7):1120-1130. doi: 10.1080/10826084.2022.2064506. Epub 2022 Apr 22.
10
Performative credibility: How opioid researchers sustain public trust during the opioid epidemic.表演性可信度:阿片类药物研究人员如何在阿片类药物泛滥期间维持公众信任。
Soc Sci Med. 2024 Jan;340:116502. doi: 10.1016/j.socscimed.2023.116502. Epub 2023 Dec 13.

引用本文的文献

1
Opioid Affinity of Diazacyclic Peptidomimetic Compounds Derived from Reduced Polyamides.源自还原型聚酰胺的二氮杂环肽模拟化合物的阿片样物质亲和力
Int J Mol Sci. 2025 Aug 25;26(17):8249. doi: 10.3390/ijms26178249.
2
Safety and Toxicology Profile of TT-6-AmHap Heroin Conjugate Vaccine.TT-6-AmHap 海洛因结合疫苗的安全性和毒理学概况
Vaccines (Basel). 2025 Jul 26;13(8):792. doi: 10.3390/vaccines13080792.
3
Chronic pain in mental disorders: An umbrella review of the prevalence, risk factors, and treatments across 957,168 people with mental disorders and 16,606,910 controls.

本文引用的文献

1
NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted.美国国家药物滥用研究所应对阿片类药物危机的药物研发重点:十大急需药物。
Neuropsychopharmacology. 2019 Mar;44(4):657-659. doi: 10.1038/s41386-018-0292-5. Epub 2018 Dec 7.
2
Prevention and Treatment of Opioid Misuse and Addiction: A Review.阿片类药物滥用和成瘾的预防和治疗:综述。
JAMA Psychiatry. 2019 Feb 1;76(2):208-216. doi: 10.1001/jamapsychiatry.2018.3126.
3
The changing landscape of naloxone availability in the United States, 2011 - 2017.
精神障碍中的慢性疼痛:对957168名精神障碍患者和16606910名对照者的患病率、危险因素及治疗方法的综合综述。
Eur Psychiatry. 2025 Aug 12;68(1):e113. doi: 10.1192/j.eurpsy.2025.10074.
4
Impact of the COVID-19 pandemic on opioid toxicity mortality rates in Nova Scotia: An interrupted time series analysis (2009-2023).新冠疫情对新斯科舍省阿片类药物中毒死亡率的影响:一项中断时间序列分析(2009 - 2023年)
Can J Public Health. 2025 Aug 6. doi: 10.17269/s41997-025-01092-8.
5
Pain among US adults before, during, and after the COVID-19 pandemic: a study using the 2019 to 2023 National Health Interview Survey.美国成年人在新冠疫情之前、期间及之后的疼痛情况:一项使用2019年至2023年全国健康访谈调查的研究
Pain. 2025 Aug 5. doi: 10.1097/j.pain.0000000000003764.
6
Differences and similarities between the genetic architecture of lifetime substance use across different substances.不同物质终生物质使用的遗传结构之间的差异与相似之处。
Psychol Med. 2025 Jul 30;55:e219. doi: 10.1017/S0033291725101293.
7
Cannabis Use in Opioid Maintenance Therapy: Prevalence, Clinical Correlates and Reasons for Use.阿片类药物维持治疗中使用大麻的情况:患病率、临床关联及使用原因
Brain Sci. 2025 Jun 29;15(7):699. doi: 10.3390/brainsci15070699.
8
Anacyphrethines A and B as potent analgesics: Multiple ion channel inhibitors with an unprecedented chemical architecture.作为强效镇痛药的异环桉叶素A和B:具有前所未有的化学结构的多离子通道抑制剂。
Acta Pharm Sin B. 2025 Jul;15(7):3725-3737. doi: 10.1016/j.apsb.2025.04.032. Epub 2025 May 21.
9
Variability in trends of opioid-related hospital utilization among U.S. Adults, 2016-2021 check.2016 - 2021年美国成年人中与阿片类药物相关的医院利用率趋势的变异性 检查
EClinicalMedicine. 2025 Jul 12;86:103355. doi: 10.1016/j.eclinm.2025.103355. eCollection 2025 Aug.
10
A learning health system model for addressing substance use: Denver Health Center for Addiction Medicine.一种用于解决药物使用问题的学习型健康系统模型:丹佛健康成瘾医学中心。
Learn Health Syst. 2025 Mar 27;9(3):e70003. doi: 10.1002/lrh2.70003. eCollection 2025 Jul.
美国 2011-2017 年纳洛酮可及性的变化情况。
Drug Alcohol Depend. 2018 Oct 1;191:361-364. doi: 10.1016/j.drugalcdep.2018.07.017. Epub 2018 Aug 30.
4
Risks of fatal opioid overdose during the first year following nonfatal overdose.非致死性药物过量后第一年致命性阿片类药物过量的风险。
Drug Alcohol Depend. 2018 Sep 1;190:112-119. doi: 10.1016/j.drugalcdep.2018.06.004. Epub 2018 Jul 4.
5
Helping to End Addiction Over the Long-term: The Research Plan for the NIH HEAL Initiative.助力长期戒除成瘾:美国国立卫生研究院治愈计划研究方案
JAMA. 2018 Jul 10;320(2):129-130. doi: 10.1001/jama.2018.8826.
6
Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016.2010-2016 年美国药物过量死亡中合成阿片类药物使用的变化。
JAMA. 2018 May 1;319(17):1819-1821. doi: 10.1001/jama.2018.2844.
7
Chemogenetic inhibition of direct pathway striatal neurons normalizes pathological, cue-induced reinstatement of drug-seeking in rats.化学遗传抑制纹状体直接通路神经元可使大鼠病理性线索诱导的觅药行为恢复正常。
Addict Biol. 2019 Mar;24(2):251-264. doi: 10.1111/adb.12594. Epub 2018 Jan 5.
8
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.注射用长效纳曲酮与每日服用丁丙诺啡-纳洛酮治疗阿片类药物依赖的疗效比较:一项随机临床非劣效性试验。
JAMA Psychiatry. 2017 Dec 1;74(12):1197-1205. doi: 10.1001/jamapsychiatry.2017.3206.
9
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.大麻素奖赏的临床前研究、大麻使用障碍的治疗方法,以及大麻素暴露的成瘾相关效应。
Neuropsychopharmacology. 2018 Jan;43(1):116-141. doi: 10.1038/npp.2017.193. Epub 2017 Aug 28.
10
Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.美国成年人的处方阿片类药物使用、滥用和使用障碍:2015 年全国毒品使用与健康调查。
Ann Intern Med. 2017 Sep 5;167(5):293-301. doi: 10.7326/M17-0865. Epub 2017 Aug 1.